![Roger Pomerantz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Pomerantz
Directeur/Membre du Conseil chez
ENLIVEX LTD.
Fortune : 2 009 $ au 31/05/2026
Profil
Roger James Pomerantz is Chairman at Silicon Therapeutics, Inc. since 2019, Chairman at Viracta Subsidiary, Inc. since 2020, Vice Chairman at Enlivex Ltd. since 2022, Director at X-Vax Technology, Inc. since 2019, Director at Verimmune, Inc., Independent Director at Aprinoia Therapeutics, Inc. since 2023, and President at Pomerantz Life Sciences Consulting Group LLC.
Former roles include President & Chief Executive Officer at Tibotec Pharmaceuticals, Chairman at CollPlant Biotechnologies Ltd. from 2020 to 2025, Chairman at Sunesis Pharmaceuticals, Inc., Chairman at Institute of Human Virology from 2002 to 2005, Chairman at ContraFect Corp.
in 2023, Chairman at Seres Therapeutics, Inc. in 2019, Chairman at Viracta Therapeutics, Inc. from 2020 to 2025, Independent Director at Intec Pharma Ltd. from 2018 to 2021, Director at Evelo Biosciences, Inc., Director at Rubius Therapeutics, Inc. from 2014 to 2019, Director at Silicon Insite, Inc. in 2019, Independent Director at Indaptus Therapeutics, Inc. from 2025 to 2026, Senior VP & Head-Licensing & Acquisitions at Merck & Co., Inc. from 2011 to 2013, Professor at Thomas Jefferson University, Professor at Molecular Pharmacology (USA) Ltd., President at Janssen R&D Ireland Ltd. from 2005 to 2010, Chief Resident at The General Hospital Corp., Senior Partner at Flagship Pioneering, Inc. from 2014 to 2019, Professor at Sidney Kimmel Medical College, Global Head-Infectious Diseases at Johnson & Johnson Pharmaceutical Group from 2005 to 2010, and President at Janssen Therapeutics, Inc. Education includes undergraduate degree from The Johns Hopkins University and doctorate from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 2 480 ( 0% ) | 2 009 $ | 31/05/2026 | |
| 21/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Roger Pomerantz
| Sociétés | Poste | Début |
|---|---|---|
| ENLIVEX LTD. | Directeur/Membre du Conseil | 23/05/2022 |
Silicon Therapeutics, Inc. | Président | 01/01/2019 |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Specializes in development of anti-tumor immune redirection therapy targeting cancer using pre-existing immune memory | Directeur/Membre du Conseil | - |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Président | 14/09/2020 |
Pomerantz Life Sciences Consulting Group LLC | President | - |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | 01/01/2019 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Directeur/Membre du Conseil | 30/11/2023 |
Anciens postes connus de Roger Pomerantz
| Sociétés | Poste | Fin |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Président | 22/12/2025 |
| COLLPLANT BIOTECHNOLOGIES LTD. | Président | 31/12/2025 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Roger Pomerantz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Pharmacology (USA) Ltd.
 Molecular Pharmacology (USA) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products | Commercial Services |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Janssen R&D Ireland Ltd. | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Human Virology
 Institute of Human Virology Other Consumer ServicesConsumer Services College/University | Consumer Services |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Johnson & Johnson Pharmaceutical Group | |
Tibotec Pharmaceuticals | |
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Janssen Therapeutics, Inc. | Health Technology |
Pomerantz Life Sciences Consulting Group LLC | |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Indaptus Therapeutics, Inc.
 Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Verimmune, Inc.
Verimmune, Inc. BiotechnologyHealth Technology Specializes in development of anti-tumor immune redirection therapy targeting cancer using pre-existing immune memory | Health Technology |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Health Technology |
Silicon Therapeutics, Inc. |
